Background/Aims: We encountered a case of posthepatectomy splenic enlargeme
nt and hypersplenism followed by disseminated intravascular coagulopathy wi
th airway hemorrhage causing death.
Methodology. We, therefore, retrospectively investigated postoperative sple
nic enlargement, hypersplenism and disseminated intravascular coagulopathy
by computed tomography and laboratory data in 57 hepatectomized patients wi
th a malignant or benign disease in the postoperative period.
Results: Of 32 patients with hepatocellular carcinoma or biliary tract carc
inoma (group A), 12 with metastatic hepatic lesions (group B), and 13 with
benign liver disease (group C); remarkable (20%) splenic enlargement was no
ted in 8 patients in group A, 2 in group B, and 2 in group C. Seven of the
12 patients were associated with liver cirrhosis, 5 with preoperative splen
omegaly, and 8 had undergone major hepatectomy. Postoperative hypersplenism
developed in 5 patients in group A, and one patient in group C. All of the
m were associated with liver cirrhosis or chronic hepatitis and preoperativ
e splenomegaly, and five had undergone hepatic lobectomy or more extensive
resections. All except for the disseminated intravascular coagulopathy case
recovered. Statistically, splenic enlargement was significantly related to
the extent of hepatectomy; lobectomy versus segmentectomy = 28.3 +/- 28.5%
(n=14) versus 12.4 +/- 13.8% (n=20), (unpaired Student's (t) test, P=0.037
). Platelet counts of the patients with liver cirrhosis or chronic hepatiti
s is lower than those without the diseases, both pre- and postoperatively (
14.0 +/- 6.0x10(4)/mm(3) vs. 21.5 +/-6.2x10(4)/mm(3), P=0.0001).
Conclusions: Postoperative hypersplenism was noted only in the patients wit
h liver cirrhosis or chronic hepatitis and preoperative splenomegaly, and d
eveloped more frequently after larger hepatectomies than after smaller hepa
tectomies; 5 (45%) of 11 versus 1 (7%) of 14, chi (2) test, P=0.026).